IRVINE, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Inari Medical Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported preliminary unaudited fourth quarter 2020 revenue. Preliminary Fourth Quarter Revenue and Business Highlights: Preliminary unaudited […]
Financial
Medical Microinstruments Appoints Healthcare Industry Veteran Mark Toland as Chief Executive Officer
Toland joins Andrew Cleeland (Chairman of the Board, MMI) in developing the field of robotic-assisted microsurgery CALCI, Italy, Jan. 12, 2021 /PRNewswire/ — Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the hiring of Mark Toland as Chief Executive Officer. He brings more than 25 years […]
Zynex Announces 117% Year over Year Order Growth and Increases Adjusted EBITDA Estimate
ENGLEWOOD, Colo., Jan. 12, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders for Q4 2020. Thomas Sandgaard, CEO of Zynex said: “We concluded 2020 with strong orders and posted […]
Azin Parhizgar, Ph.D. Joins InnovHeart as Independent Member of the Board of Directors
NEWTON, Mass. and MILANO, ITALY, Jan. 12, 2021 /PRNewswire/ — InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation, announced today the appointment of successful serial entrepreneur and medical device executive Dr. Azin Parhizgar, Ph.D. as an Independent Member of the Board of Directors. Dr. Parhizgar […]
Impulse Dynamics Closes $60 Million Financing
Funding to Accelerate Clinical and Product Development Pipelines, Commercialization of Optimizer Smart System for Heart Failure MARLTON, N.J.–(BUSINESS WIRE)–Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with heart failure, today announced the completion of a $60 million supplemental Series D crossover financing with new […]
Rapid Medical Announces Appointment of James Romero as President, Americas
Experienced Neurovascular Device Executive will Lead Commercialization in US, Canada and LATAM YOKNEAM, Israel & FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Rapid Medical, a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces James Romero as the company’s President, Americas. Mr. Romero will oversee the growth and […]
Penumbra Announces Preliminary Unaudited Revenue for the Fourth Quarter and Full Year 2020
ALAMEDA, Calif., Jan. 11, 2021 /PRNewswire/ — Penumbra, Inc. (the “Company”) (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced certain unaudited preliminary revenue results for the fourth quarter and full year 2020 ahead of its participation at the 39th Annual J.P. Morgan Healthcare Conference on January 11-14, 2021. Q4 Revenue Highlights […]
CardioFocus® Announces Expanded Distribution Partnership With MicroPort™ CRM To Include Spain And Portugal
MARLBOROUGH, Mass., Jan. 11, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that it has expanded its existing French distribution partnership agreement with MicroPort CRM in France to include both Spain and Portugal. “We are pleased to be represented by MicroPort CRM in France and have been very impressed by […]
Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia’s Board of Directors
SAN CARLOS, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, welcomes Krisztina Zsebo, Ph.D., a 31-year veteran of the biotech industry, to its Board of Directors following her election at BioCardia’s 2020 Annual Meeting of Stockholders in December […]
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020
Fourth quarter 2020 worldwide revenue of $57.7 million (U.S. $47.4 million, International $10.3 million) MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced preliminary financial results for the fourth quarter and full year 2020. “We are pleased […]
Recent
New HFSA Scientific Statement Provides Practical Guidance for Managing Heart Failure with Mildly Reduced Ejection Fraction
Sonorous Neurovascular Receives FDA 510(k) Clearance for BosCATH™ Neurovascular Catheter
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
Popular
- No commented posts yet